-
21.
公开(公告)号:US20200156997A1
公开(公告)日:2020-05-21
申请号:US16682108
申请日:2019-11-13
Applicant: CORNING INCORPORATED
Inventor: Timothy Michael Gross , Adam Robert Sarafian , Jingshi Wu , Zheming Zheng
Abstract: Laminated glass articles and glass-based articles are disclosed. According to one embodiment, a laminated glass article includes a glass core layer comprising an average core coefficient of thermal expansion CTEC and at least one glass clad layer fused directly to the glass core layer, the at least one glass clad layer comprising an average clad coefficient of thermal expansion CTECL. CTEC is greater than or equal to CTECL. The glass core layer, the glass clad layer, or both, include a hydrogen-containing core zone.
-
公开(公告)号:US20200156996A1
公开(公告)日:2020-05-21
申请号:US16682063
申请日:2019-11-13
Applicant: CORNING INCORPORATED
Inventor: Timothy Michael Gross , Adam Robert Sarafian , Jingshi Wu , Zheming Zheng
Abstract: Glass-based articles that include a compressive stress layer extending from a surface of the glass-based article to a depth of compression are formed by exposing glass-based substrates to water vapor containing environments. The methods of forming the glass-based articles may include elevated pressures and/or multiple exposures to water vapor containing environments.
-
公开(公告)号:US20200156995A1
公开(公告)日:2020-05-21
申请号:US16681995
申请日:2019-11-13
Applicant: CORNING INCORPORATED
Inventor: Timothy Michael Gross , Adam Robert Sarafian , Jingshi Wu , Zheming Zheng
Abstract: Glass-based articles that include a compresive stress layer extending from a surface of the glass-based article to a depth of compression are formed by exposing glass-based substrates to water vapor containing environments. The glas-based substrates are substantially free or free of alkali metal oxides. The methods of forming the glass-based articles may include elevated pressures and/or multiple exposures to water vapor containing environments.
-
公开(公告)号:US11963929B2
公开(公告)日:2024-04-23
申请号:US18310964
申请日:2023-05-02
Applicant: CORNING INCORPORATED
Inventor: Connor Thomas O'Malley , Sinue Gomez-Mower , Weirong Jiang , Joseph Michael Matusick , Christie Leigh McCarthy , Christy Lynn Chapman , John Stephen Peanasky , Shivani Rao Polasani , James Ernest Webb , Michael Clement Ruotolo, Jr. , Bryan James Musk , Jared Seaman Aaldenberg , Eric Lewis Allington , Douglas Miles Noni, Jr. , Amber Leigh Tremper , Kristen Dae Waight , Kevin Patrick McNelis , Patrick Joseph Cimo , Steven Edward DeMartino , Robert Anthony Schaut , Adam Robert Sarafian
CPC classification number: A61J1/1468 , B65D23/0821
Abstract: Disclosed herein are glass pharmaceutical vials having sidewalls of reduced thickness. In embodiments, the glass pharmaceutical vial may include a glass body comprising a sidewall enclosing an interior volume. An outer diameter D of the glass body is equal to a diameter d1 of a glass vial of size X as defined by ISO 8362-1, wherein X is one of 2R, 3R, 4R, 6R, 8R, 10R, 15R, 20R, 25R, 30R, 50R, and 100R as defined by ISO 8362-1. However, the sidewall of the glass pharmaceutical vial comprises an average wall thickness Ti that is less than or equal to 0.85*s1, wherein s1 is a wall thickness of the glass vial of size X as defined by ISO 8362-1 and X is one of 2R, 3R, 4R, 6R, 8R, 10R, 15R, 20R, 25R, 30R, 50R, and 100R as defined by ISO 8362-1.
-
公开(公告)号:US20240034666A1
公开(公告)日:2024-02-01
申请号:US18227470
申请日:2023-07-28
Applicant: CORNING INCORPORATED
Inventor: Tiphaine Fevre , Scott Michael Jarvis , Adam Robert Sarafian , Emily Kathryn Sarafian , Joseph Martin Wright
Abstract: A fining package for a glass composition may include a sulfate or a sulfide in an amount from about 0.001 to about 1 mol % of the glass composition. The fining package may include a multivalent compound, such as CeO2, SnO2, or Fe2O3, in an amount from about 0.001 to about 1 mol % of the glass composition. The fining package may be sulfide-free. The fining package may be free from a reducing agent for reducing sulfate to sulfide. The fining package may be free of at least one of Cl, F, Sn, Ce, and As. The glass composition may be used to form glass tubing. The glass tubing may be used to form a pharmaceutical packaging.
-
公开(公告)号:US11767258B2
公开(公告)日:2023-09-26
申请号:US16682063
申请日:2019-11-13
Applicant: CORNING INCORPORATED
Inventor: Timothy Michael Gross , Adam Robert Sarafian , Jingshi Wu , Zheming Zheng
CPC classification number: C03C21/007 , C03C3/097
Abstract: Glass-based articles that include a compressive stress layer extending from a surface of the glass-based article to a depth of compression are formed by exposing glass-based substrates to water vapor containing environments. The methods of forming the glass-based articles may include elevated pressures and/or multiple exposures to water vapor containing environments.
-
公开(公告)号:US20230270627A1
公开(公告)日:2023-08-31
申请号:US18310964
申请日:2023-05-02
Applicant: Corning Incorporated
Inventor: Connor Thomas O'Malley , Sinue Gomez-Mower , Weirong Jiang , Joseph Michael Matusick , Christie Leigh McCarthy , Christy Lynn Chapman , John Stephen Peanasky , Shivani Rao Polasani , James Ernest Webb , Michael Clement Ruotolo, JR. , Bryan James Musk , Jared Seaman Aaldenberg , Eric Lewis Allington , Douglas Miles Noni, JR. , Amber Leigh Tremper , Kristen Dae Waight , Kevin Patrick McNelis , Patrick Joseph Cimo , Steven Edward DeMartino , Rob Anthony Schaut , Adam Robert Sarafian
CPC classification number: A61J1/1468 , B65D23/0821
Abstract: Disclosed herein are glass pharmaceutical vials having sidewalls of reduced thickness. In embodiments, the glass pharmaceutical vial may include a glass body comprising a sidewall enclosing an interior volume. An outer diameter D of the glass body is equal to a diameter d1 of a glass vial of size X as defined by ISO 8362-1, wherein X is one of 2R, 3R, 4R, 6R, 8R, 10R, 15R, 20R, 25R, 30R, 50R, and 100R as defined by ISO 8362-1. However, the sidewall of the glass pharmaceutical vial comprises an average wall thickness Ti that is less than or equal to 0.85*s1, wherein s1 is a wall thickness of the glass vial of size X as defined by ISO 8362-1 and X is one of 2R, 3R, 4R, 6R, 8R, 10R, 15R, 20R, 25R, 30R, 50R, and 100R as defined by ISO 8362-1.
-
公开(公告)号:US20230270626A1
公开(公告)日:2023-08-31
申请号:US18310956
申请日:2023-05-02
Applicant: CORNING INCORPORATED
Inventor: Christy Lynn Chapman , Sinue Gomez-Mower , Weirong Jiang , Joseph Michael Matusick , Christie Leigh McCarthy , Connor Thomas O'Malley , John Stephen Peanasky , Shivani Rao Polasani , James Ernest Webb , Michael Clement Ruotolo , Bryan James Musk , Jared Seaman Aaldenberg , Eric Lewis Allington , Douglas Miles Noni , Amber Leigh Tremper , Kristen Dae Waight , Kevin Patrick McNelis , Patrick Joseph Cimo , Steven Edward DeMartino , Rob Anthony Schaut , Adam Robert Sarafian
CPC classification number: A61J1/1468 , B65D23/0821
Abstract: Disclosed herein are glass pharmaceutical vials having sidewalls of reduced thickness. In embodiments, the glass pharmaceutical vial may include a glass body comprising a sidewall enclosing an interior volume. An outer diameter D of the glass body is equal to a diameter d1 of a glass vial of size X as defined by ISO 8362-1, wherein X is one of 2R, 3R, 4R, 6R, 8R, 10R, 15R, 20R, 25R, 30R, 50R, and 100R as defined by ISO 8362-1. However, the sidewall of the glass pharmaceutical vial comprises an average wall thickness Ti that is less than or equal to 0.85*s1, wherein s1 is a wall thickness of the glass vial of size X as defined by ISO 8362-1 and X is one of 2R, 3R, 4R, 6R, 8R, 10R, 15R, 20R, 25R, 30R, 50R, and 100R as defined by ISO 8362-1.
-
29.
公开(公告)号:US20230233407A1
公开(公告)日:2023-07-27
申请号:US18128681
申请日:2023-03-30
Applicant: CORNING INCORPORATED
CPC classification number: A61J1/065 , A61J1/1412 , B65D39/0052 , C03C15/02 , B32B17/06 , B65B7/161 , A61J2200/44 , Y10T428/1352 , Y10T428/13 , Y10T428/1328 , Y10T428/1355 , Y10T428/1397 , Y10T428/131 , Y10T428/1331
Abstract: A sealed pharmaceutical container includes a shoulder, a neck extending from the shoulder, and a flange extending from the neck. The flange includes an inclined sealing surface defining an opening in the sealed pharmaceutical container. The sealed pharmaceutical container also includes a sealing assembly including a stopper extending over the sealing surface of the flange and a cap securing the stopper to the flange. The stopper has a glass transition temperature (Tg) that is greater than or equal to −70° C. and less than or equal to −45° C. The sealing assembly maintains a helium leakage rate of the sealed pharmaceutical container of less than or equal to 1.4×10−6 cm3/s as the sealed pharmaceutical container is cooled to a temperature of less than or equal to −45° C.
-
公开(公告)号:US20230144783A1
公开(公告)日:2023-05-11
申请号:US17981037
申请日:2022-11-04
Applicant: CORNING INCORPORATED
Inventor: Dane Alphanso Christie , Adam Robert Sarafian , Jiangtao Wu
CPC classification number: A61J1/1412 , B65D1/023 , B65B7/2842 , A61J2200/44
Abstract: A sealed pharmaceutical container including: a shoulder; a neck extending from the shoulder; a flange extending from the neck, the flange including: an underside surface extending from the neck; an outer surface extending from the underside surface, the outer surface defining an outer diameter of the flange; and an upper sealing surface extending between the outer surface and an inner surface defining an opening in the sealed pharmaceutical container, and a sealing assembly including: a stopper including a sealing portion extending over the upper sealing surface of the flange and covering the opening, and an insertion portion extending into the opening and in contact with the inner surface of the flange, the stopper having a first CTE; and a filler member encased within the stopper and having a second CTE, the second CTE being lower than the first CTE.
-
-
-
-
-
-
-
-
-